Skip to main content

Advertisement

Log in

Role of the radiologist at HCC multidisciplinary conference and use of the LR-TR algorithm for improving workflow

  • Special Section : HCC Treatment
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Multidisciplinary conferences (MDCs) play a major role in management and care of oncology patients. Hepatocellular carcinoma (HCC) is a complex disease benefiting from multidisciplinary discussions to determine optimal patient management. A multitude of liver-directed locoregional therapies have emerged allowing for more options for treatment of HCC. A radiologist dedicated to HCC-MDC is an important member of the team contributing to patient care in multiple ways. The radiologist plays a key role in image interpretation guiding initial therapy discussions as well as interpreting post-treatment imaging following liver-directed therapy. Standardization of image interpretation can lead to more consistent treatment received by the patient as well as accurate assessment of transplant eligibility. The radiologist can facilitate this process using structured reporting that is also supported by stakeholders involved in interdisciplinary management of liver diseases. The Liver Imaging Reporting and Data System (LI-RADS), is a living document which offers a standardized reporting algorithm for consistent communication of radiologic findings for HCC screening and characterization of liver observations in patients at risk for HCC. The LI-RADS post-treatment algorithm (LR-TR algorithm) has been developed to standardize liver observations following liver-directed locoregional therapy. This review article focuses on the role of the radiologist at HCC-MDC and implementation of the LR-TR algorithm for improving workflow.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Siddique O, Yoo E, Perumpail R, et al. The importance of a multidisciplinary approach to hepatocellular carcinoma. Journal of Multidisciplinary Healthcare. 2017; Volume 10:95–100. https://www.dovepress.com/the-importance-of-a-multidisciplinary-approach-to-hepatocellular-carci-peer-reviewed-article-JMDH.

  2. Gadsden MM, Kaplan DE. Multidisciplinary Approach to HCC Management: How Can This Be Done? Dig Dis Sci. 2019;64(4):968-975

  3. Chang TT, Sawhney R, Monto A, Davoren JB, Kirkland JG, Steward L, et al. Implementation of a multidisciplinary treatment team for hepatocellular cancer at a Veterans Affairs Medical Center improves survival. HPB (Oxford). 2008; 10:405-11

  4. Yopp AC, Mansour JC, Beg MS, et al. Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Ann Surg Oncol. 2014;21(4):1287-1295.

  5. Sinn DH, Choi GS, Park HC, Kim JM, Kim H, et al. (2019) Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients. PLOS ONE 14(1): e0210730.

  6. Charriere, B.; Muscari, F.; Maulat, C.; Bournet, B.; Bonnet, D.; Bureau, C.; Otal, P.; Peron, J.M.; Suc, B. Outcomes of patients with hepatocellular carcinoma are determined in multidisciplinary team meetings. J. Surg. Oncol. 2017, 115, 330–336.

  7. Elsayes KM, Hooker JC, Agrons MM, et al. (2017) 2017 Version of LI-RADS for CT and MR Imaging: An Update. Radiographics. 37(7):1994–2017

    Article  Google Scholar 

  8. https://www.acr.org/-/media/ACR/Files/Clinical-Resources/LIRADS/LI-RADS-2018-Manual-5Dec18.pdf

  9. Elsayes KM, Kielar AZ, Chernyak V, et al. LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance. J Hepatocell Carcinoma. 2019; 6:49–69.

  10. Kamath A, Roudenko A, Hecht E, Sirlin C, Chernyak V, Fowler K, Mitchell DG. CT/MR LI-RADS 2018: clinical implications and management recommendations. Abdom Radiol (NY). 2019 Apr;44(4):1306-1322. https://doi.org/10.1007/s00261-018-1868-6. PMID: 30671612.

  11. Chernyak V, Fowler KJ, Kamaya A, et al. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. Radiology. 2018;289(3):816–830.

  12. Kielar A, Fowler KJ, Lewis S, et al. Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdom Radiol (NY). 2018;43(1):218–230.

  13. Chung R, Rosenkrantz AB, Shanbhogue KP. Expert radiologist review at a hepatobiliary multidisciplinary tumor board: impact on patient management. Abdom Radiol (NY). 2020 Nov;45(11):3800-3808. https://doi.org/10.1007/s00261-020-02587-3. PMID: 32444889.

  14. Masch WR, Parikh ND, Licari TL, Mendiratta-Lala M, Davenport MS. Radiologist Quality Assurance by Nonradiologists at Tumor Board. J Am Coll Radiol. 2018 Sep;15(9):1259-1265. https://doi.org/10.1016/j.jacr.2018.04.021. Epub 2018 Jun 14. PMID: 29866627.

  15. Yokoo, T., Singal, A.G., Diaz de Leon, A. et al. Prevalence and clinical significance of discordant LI-RADS® observations on multiphase contrast-enhanced MRI in patients with cirrhosis. Abdom Radiol 45, 177–187 (2020). https://doi.org/10.1007/s00261-019-02133-w

  16. Flusberg M, Ganeles J, Ekinci T, Goldberg-Stein S, Paroder V, Kobi M, Chernyak V. Impact of a Structured Report Template on the Quality of CT and MRI Reports for Hepatocellular Carcinoma Diagnosis. J Am Coll Radiol. 2017 Sep;14(9):1206-1211. https://doi.org/10.1016/j.jacr.2017.02.050. Epub 2017 May 6. PMID: 28483546.

  17. Poullos PD, Tseng JJ, Melcher ML, Concepcion W, Loening AM, Rosenberg J, Willmann JK. Structured Reporting of Multiphasic CT for Hepatocellular Carcinoma: Effect on Staging and Suitability for Transplant. AJR Am J Roentgenol. 2018 Apr;210(4):766-774. https://doi.org/10.2214/ajr.17.18725. Epub 2018 Feb 22. PMID: 29470153.

  18. Young S, Taylor AJ, Sanghvi T. Post Locoregional Therapy Treatment Imaging in Hepatocellular Carcinoma Patients: A Literature-based Review. J Clin Transl Hepatol. 2018;6(2):189-197. https://doi.org/10.14218/jcth.2017

  19. Mendiratta-Lala M, Masch WR, Shampain K, Zhang A et al. MRI Assessment of Hepatocellular Carcinoma after Local-Regional Therapy: A Comprehensive Review. Radiology: Imaging Cancer 2020 2:1. doi.org/https://doi.org/10.1148/rycan.2020190024

  20. Covey AM and Hussain SM. Liver-Directed Therapy for Hepatocellular Carcinoma: An Overview of Techniques, Outcomes, and Posttreatment Imaging Findings. AJR Am J Roentgenol 2017 209:1, 67-76

  21. Shi W, He Y, Ding W, et al. (1064) Contrast-enhanced ultra- sonography used for post-treatment responses evaluation of radiofrequency ablations for hepatocellular carcinoma: a meta- analysis. Br J Radiol 2016(89):20150973

  22. Hunt SJ, et al. Radiologic monitoring of hepatocellular carcinoma tumor viability after transhepatic arterial chemoembolization: estimating the accuracy of contrast-enhanced cross-sectional imaging with histopathologic correlation. J Vasc Interv Radiol. 2009; 20(1):30–8. [PubMed: 19028117]

  23. Ehman EC, et al. Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy. Abdom Radiol (NY). 2016; 41(11):2161–2168. [PubMed: 27484789]

  24. Seo, N., Kim, M.S., Park, MS. et al. Correction to: Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017. Eur Radiol (2020). https://doi.org/10.1007/s00330-020-07444-x

  25. Shropshire EL, Chaudhry M, Miller CM, et al. LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy. Radiology. 2019;292(1):226-234. https://doi.org/10.1148/radiol.2019182135

  26. Chaudhry M, McGinty KA, Mervak B, Lerebours R, Li C, Shropshire E, Ronald J, Commander L, Hertel J, Luo S, Bashir MR, Burke LMB. The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma. Radiology. 2020 Feb;294(2):320-326. https://doi.org/10.1148/radiol.2019191581. Epub 2019 Dec 17. PMID: 31845843.

  27. Yun Zhang, Jinju Wang, Hui Li, Tianying Zheng, Hanyu Jiang, Mou Li, Bin Song. Performance of LI-RADS version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single hepatocellular carcinoma after radiofrequency ablation. Ann Transl Med. 2020 Mar;8(6):388. https://doi.org/10.21037/atm.2020.03.120.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anuradha S. Shenoy-Bhangle.

Ethics declarations

Conflict of interest

Leo L Tsai MD, PhD, MSc, Consultant, Agile Devices—not relevant to this paper. No other Disclosures.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shenoy-Bhangle, A.S., Tsai, L.L., Masciocchi, M. et al. Role of the radiologist at HCC multidisciplinary conference and use of the LR-TR algorithm for improving workflow. Abdom Radiol 46, 3558–3564 (2021). https://doi.org/10.1007/s00261-021-03094-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-021-03094-9

Keywords

Navigation